WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke HUMABODY wurde als Wortmarke am 17.12.2014 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1281026 |
| Registernummer | 013028683 |
| Länder | 
|
| Basismarke |
Nr. 013028683,
18. November 2014
|
| Anmeldedatum | 17. Dezember 2014 |
| Ablaufdatum | 17. Dezember 2024 |
Markeninhaber
Meditrina,
Babraham Research Campus
GB
Babraham Research Campus
GB
Markenvertreter
15 Clare Road
Halifax HX1 2HY
GB
Waren und Dienstleistungen
01
Chemicals used in industry and science; chemicals for
laboratory research purposes; antibodies and antibody
fragments for scientific and laboratory use; monoclonal
antibodies and antibody fragments for scientific and
laboratory use; antibodies and antibody fragments for
scientific research purposes; antibody reagents for
scientific and laboratory use; antibodies and antibody
fragments for use in the discovery, preclinical and clinical
development of therapeutic products (term considered too
vague by the International Bureau - Rule 13.2.b) of the
Common Regulations)
05
Pharmaceutical and veterinary preparations; therapeutic
preparations for medical and veterinary purposes;
antibodies; antibody fragments; monoclonal antibody
therapies (term considered too vague by the International
Bureau - Rule 13.2.b) of the Common Regulations); antibodies
and antibody fragments for medical and veterinary
diagnostics; antibodies and antibody fragments for use in
the discovery, preclinical and clinical development of
therapeutic products; antibodies and antibody fragments for
use in the manufacture of therapeutic products
40
Treatment and transformation of materials, namely the
manufacture of chemicals, biologicals, antibodies and
antibody fragments (term considered too vague by the
International Bureau - Rule 13.2.b) of the Common
Regulations); contract manufacturing services; services for
the custom manufacture of therapies using antibodies and
antibody fragments
42
Scientific and technological services and research and
design relating thereto; laboratory services relating to
antibodies and antibody fragments (term considered too vague
by the International Bureau - Rule 13.2.b) of the Common
Regulations); research into the development of antibodies
and antibody fragments; provision of antibodies and antibody
fragments for medical and veterinary purposes (term
considered too vague by the International Bureau - Rule
13.2.b) of the Common Regulations); engineering of
antibodies and antibody fragments; scientific services
relating to the discovery, preclinical and clinical
development of therapeutic products; consultancy services
relating thereto
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 20. Juli 2023 | 2023/31 Gaz | RAW: Holder Rights Restriction | |
| 19. Februar 2018 | 2018/9 Gaz | IN | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 22. Juni 2017 | 2017/26 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 20. März 2017 | 2017/12 Gaz | CN | Ablehnung |
| 14. März 2017 | 2017/11 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 23. Januar 2017 | 2017/5 Gaz | IN | Ablehnung |
| 10. Januar 2017 | 2017/5 Gaz | AU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 08. Dezember 2016 | 2016/51 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 16. November 2016 | 2016/47 Gaz | CH | Ablehnung |
| 07. Juli 2016 | 2016/30 Gaz | JP | Ablehnung |
| 20. Juni 2016 | 2016/26 Gaz | KR | Ablehnung |
| 08. Februar 2016 | 2016/7 Gaz | AU | Ablehnung |
| 11. Januar 2016 | 2016/3 Gaz | US | Ablehnung |
| 17. Dezember 2014 | 2015/51 Gaz | EM | Eintragung |
ID: 141281026